Trial · NCT03024827
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Heart Rate | Up to 6 months | |
| Primary | Blood Pressure | Up to 6 months | |
| Primary | Weight | Up to 6 months | |
| Primary | Complete Blood Count (CBC) and Differential | Up to 6 months | |
| Primary | Sodium, potassium, chloride, calcium, magnesium, phosphate and carbon dioxide (mmol/L) | Up to 6 months | |
| Primary | Blood Urea Nitrogen (mmol/L) | Up to 6 months | |
| Primary | Creatinine (umol/L) | Up to 6 months | |
| Primary | Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Gamma-glutamyl transferase (GGT) and Lipase (U/L) | Up to 6 months | |
| Primary | Total and Direct Bilirubin (umol/L) | Up to 6 months | |
| Primary | Albumin (g/L) | Up to 6 months | |
| Primary | Total Cholesterol and Triglyceride (mmol/L) | Up to 6 months | |
| Primary | Clobazam and Norclobazam Levels (umol/L) | Up to 6 months | For participants taking clobazam who become excessively sedated |
| Primary | Clonazepam Level (umol/L) | Up to 6 months | For participants taking clonazepam who become excessively sedated |
| Primary | Urine Ketones | Up to 6 months | For participants on the ketogenic diet |
| Primary | Trough Level of Concomitant Anti-Convulsants | Up to 7 months | Measure interactions with any anti-convulsants participants may be already on |
| Primary | Adverse Events | Through study completion, up to 7 months | Side effect rating scale, includes items related to sleepiness/lethargy, irritability, nausea/vomiting and diarrhea |
| Primary | 2-hour Electroencephalogram (EEG) Recording | Up to 6 months | |
| Secondary | Seizure Frequency Log Book | Through study completion, up to 7 months | |
| Secondary | Modified Quality of Life in Children with Epilepsy Questionnaire (QOLCE) | Through study completion, up to 7 months | |
| Secondary | Cannabidiol (CBD) (ng/mL) | Up to 7 months | Levels in blood |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03024827/registered